Authors


Richa Tandon, MD

Latest:

Disseminated Mycobacterium avium-intracellulare Infection in a Person With AIDS With Cutaneous and CNS Lesions

We present the case of a 55-year-old man with AIDS who had disseminated Mycobacterium avium-intracellulare (MAI) infection who was nonadherent to antiretroviral treatment and prophylaxis for opportunistic infections.


Richard Elion, MD

Latest:

Antiretroviral Treatment Update From the 17th International AIDS Conference

The 17th International AIDS Conference was held in Mexico City from August 3 to 8, 2008. This conference attracted more than 20,000 participants and provided some significant new insights into HIV therapeutics.


Richard L. Oehler, MD

Latest:

An HIV-Infected Patient With Fever, Pancytopenia, and Renal Failure: Is This End-Stage AIDS?

Histoplasmosis is a fungal infection caused by Histoplasma capsulatum. Although immunocompetent persons with H capsulatum infections are usually asymptomatic, several clinical syndromes can manifest in immunocompromised patients.


Richard Serrao, MD

Latest:

Disseminated Mycobacterium avium-intracellulare Infection in a Person With AIDS With Cutaneous and CNS Lesions

We present the case of a 55-year-old man with AIDS who had disseminated Mycobacterium avium-intracellulare (MAI) infection who was nonadherent to antiretroviral treatment and prophylaxis for opportunistic infections.


Rita Baron-Faust

Latest:

HIV and Hypertension: The Need to Pay More Heed

About a third of HIV-positive patients have high blood pressure. Is this a predictable consequence of ordinary aging, or do their history of HIV infection and treatment play a role? Whatever the explanation, many of these patients don't take the problem seriously enough.


Robert L. Moser, MD

Latest:

An HIV-Infected Patient With Nocardia asteroides Bilateral Pneumonia

Pneumonia remains a concern for persons with long-standing HIV infection. We pre­sent a case of a 43-year-old HIV-infected woman with bilateral pneumonia whose pre­sentation suggested the cause was a bacterial pathogen.


Robert Staudinger, MD

Latest:

Neurosarcoidosis in a Patient With AIDS

Neurosarcoidosis has not been reported in patients with HIV infection. We present the case of a patient with AIDS in whom spinal cord sarcoidosis developed years after highly active antiretroviral therapy was initiated and her immune system was reconstituted. Treatment with prednisone resulted in resolution of MRI lesions and symptoms. Since patients with HIV-1 infection who are receiving antiretroviral therapy can survive for many years, physicians should be aware of chronic immune restoration disease involving the CNS.


Rodger D. MacArthur, MD

Latest:

HIV Infection in the Elderly

There is general consensus among public health authorities that the elderly are not being screened for HIV as frequently as are younger persons. But there is compelling reason to do so.


Saarah Arshad, MD

Latest:

Subacute Onset of Paralysis in a Person With AIDS

The pathogen Toxoplasma gondii is an intracellular protozoan that most commonly presents in persons with AIDS as reactivation of latent infection.


Sadao Jinno, MD

Latest:

Progression of Kaposi Sarcoma Associated With Iatrogenic Cushing Syndrome in a Person With HIV/AIDS

The prevalence of Kaposi sarcoma (KS) in HIV-infected persons in the pre-HAART era has been reported to be as high as 20%. Although AIDS-associated KS has declined by more than 80% since the introduction of highly active antiretroviral regimens, KS remains an important malignancy in the HIV-infected population


Sandro K. Cinti, MD

Latest:

Non–AIDS-Defining Cancers: Should Antiretroviral Therapy Be Initiated Earlier?

Much has been written about the increase in non–AIDS-defining cancers in HIV-infected persons over the past decade.


Sophia Archuleta, MD

Latest:

Legionnaires Disease in a Patient With AIDS

Legionella species are among the leading causes of community-acquired pneumonia (CAP) in the general population, and although rare in patients with HIV infection, Legionella pneumonia is associated with significant morbidity and mortality


Stuart C. Ray, MD

Latest:

Severe Pruritus After Completing Pegylated Interferon for Hepatitis C

In most HIV-infected persons, one or more dermatological conditions develop at some point during their lifetime.1 Among the spectrum of dermatological diseases, those associated with pruritus are among the most common.


Summerpal S. Kahlon, MD

Latest:

Mycobacterium avium-intracellulare Complex Immune Reconstitution Inflammatory Syndrome in HIV/AIDS Presenting as Osteomyelitis

We report a case of osteomyelitis due to Mycobacterium avium-intracellulare complex (MAC) in an AIDS patient shortly after the initiation of antiretroviral therapy with subsequent immune reconstitution inflammatory syndrome (IRIS).


Susan C. Ball, MD, MPH

Latest:

A "Usual" Case of Syphilis

Mr D is a 38-year-old African American man in whom AIDS had been diagnosed in 2001; he had responded well to antiretroviral therapy, with a recent CD4+ cell count of 376/µL and an HIV RNA level less than 50 copies/mL. He presented to our clinic complaining of a mildly tender "lump" on the left side of his neck, which he first noticed a week ago. He denied fever, chills, sweats, cough, anorexia, weight loss, and urinary symptoms but had a sore throat for 2 days.


Tejal Gandhi, MD

Latest:

Non–AIDS-Defining Cancers: Should Antiretroviral Therapy Be Initiated Earlier?

Much has been written about the increase in non–AIDS-defining cancers in HIV-infected persons over the past decade.


Todd McNiff, MD, MSPH

Latest:

CCR5 Antagonists in the Treatment of HIV-Infected Persons: Is Their Cancer Risk Increased, Decreased, or Unchanged?

With the FDA approval of a new small-molecule drug to treat HIV infection by blocking the CCR5 chemokine receptor and with several other drugs of this class in development for this and other indications, there is an increased interest in determining the potential influence on tumor promotion or suppression that blocking this receptor may have. Large, long-term clinical studies would be the ideal method for evaluating the potential increase in cancer risk, and at least one such study is under way (see http://clinicaltrials.gov/show/NCT00665561?order=49).


Veronica Hackethal MD

Latest:

Very Early ART: Does a Curative Window Exist?

This case study of 2 patients suggests that very early antiretroviral therapy is not enough to prevent formation of latent viral reservoirs and prevent HIV rebound on treatment discontinuation.


Veronica Hackethal, MD

Latest:

HIV-Positive Organ Transplant

Research supports liver and kidney transplantation in patients with HIV infection, but referral rates are low.


Victoria Sharp, MD

Latest:

Schistosoma mansoni Colitis in an AIDS Patient

A 33-year-old man from the Ivory Coast (who had been living in the United States for the past 8 years) received a diagnosis of AIDS when he presented with Pneumocystis jiroveci pneumonia. His CD4+ cell count was 6/µL, and his HIV RNA level was 575,000 copies/mL. He also presented with altered sensorium and seizure activity and was found to have obstructive hydrocephalus and ring-enhancing lesions in both cerebellar hemispheres and basal ganglia. Results of polymerase chain reaction testing of cerebrospinal fluid for Toxoplasma gondii were positive, and treatment for toxoplasmosis was started. A ventricular-peritoneal shunt was placed.


Wayne Duke, MD

Latest:

Extensive Development of Flat Warts as a Cutaneous Manifestation of Immune Reconstitution Syndrome

Cutaneous manifestations of immune recovery in response to highly active antiretroviral therapy may account for up to 54% to 78% of the clinical presentations of the immune reconstitution syndrome (IRS)


Wei Wei Lee, MD, MPH

Latest:

Lymphoma Presenting as Cranial Nerve Neuropathies in HIV-Infected Patients

Patients with HIV infection are at increased risk for several types of malignancy. After Kaposi sarcoma, non-Hodgkin lymphoma (NHL) is the second most common HIV-associated cancer.1


William M. Valenti, MD

Latest:

Expanding HIV Testing: Overcoming Physician Barriers

In a recent AIDS Reader editorial, Joel E. Gallant called for clinicians who treat persons with HIV/AIDS to “become vocal advocates for routine HIV screening,


William S. Breitbart, MD

Latest:

Psychiatric Aspects of Comorbid HIV/AIDS and Pain, Part 2

Pain is recognized as a significant disability in HIV-infected persons.

© 2024 MJH Life Sciences

All rights reserved.